First in Human Study With NG-641, a Tumour Selective Transgene Expressing Adenoviral Vector
Clinical trial NCT04053283 · COMPLETED
Trial details
- NCT number
- NCT04053283
- Sponsor
- Akamis Bio
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2023-08-31
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.